Mds Mpn clinical trials

Explore recruiting mds mpn clinical trials.

Recruiting mds mpn studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Mds Mpn trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

AVENHIR trial: Phase II study with safety run-in of Azacitidine (AZA) combined with Venetoclax (VEN) in patients with higher-risk Chronic Myelomonocytic Leukemia (CMML)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase II, Single-Arm, Open-Label Study to Assess the Efficacy and Safety of Canakinumab for the Treatment of Anemia in Patients with IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes or MDS/MPN CANFIRE Trial

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 1, Open-Label, Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms

Italy, Spain, Finland

Human Pharmacology (Phase I)- Other EU CTIS Study details

Graft vs Host Disease Prophylaxis in unrelated donor transplantation: a randomized clinical trial comparing PTCY vs ATG

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 1b/2, Open-Label, Dose Finding, and Expansion Study of the Bcl‑2 Inhibitor BGB‑11417 in Patients With Myeloid Malignancies

Spain, France, Germany, Italy

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Mds Mpn trials by city

Mds Mpn in Toronto Mds Mpn in Vancouver Mds Mpn in Montreal Mds Mpn in Calgary Mds Mpn in Edmonton Mds Mpn in Ottawa Mds Mpn in Winnipeg Mds Mpn in Quebec City Mds Mpn in Hamilton Mds Mpn in Kitchener Mds Mpn in London Mds Mpn in Halifax Mds Mpn in New York Mds Mpn in Los Angeles Mds Mpn in Chicago Mds Mpn in Houston

Mds Mpn clinical trials

Recruiting mds mpn studies right now

Anti-NKG2A Monoclonal Antibody for AML or MDS Patients Undergoing Haploidentical Transplantation

Clinical Study of Azacitidine Combined With Ruxolitinib in the Treatment of Higher-risk MDS/MPN

Phase 1/ Phase 2 Study to Assess Safety and Efficacy of Orally Administered JBI-802 in Subjects With Myeloproliferative Neoplasms (MPN) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) With Thrombocytosis

Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)

5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies

Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies

A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

A Study of BGB-11417 in Participants With Myeloid Malignancies

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms